High Throughput Screening (HTS): Market Research Report

Date: January 10, 2016
Pages: 304
Price:
US$ 4,500.00
Publisher: Global Industry Analysts, Inc
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: HEFC94AC1ACEN
Leaflet:

Download PDF Leaflet

High Throughput Screening (HTS): Market Research Report
This report analyzes the worldwide markets for High Throughput Screening (HTS) in US$ Million by the following Product Segments: Consumables/Reagents, Instruments, and Software and Services. The report also analyses the market by the following Technology Types: Label-Free Technology, Cell-Based Assay, and Others.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022.

Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 104 companies including many key and niche players such as -
  • Agilent Technologies, Inc.
  • Aurora Biomed, Inc.
  • Axxam SpA
  • BD Biosciences
  • Danaher Corporation
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Product Types
Consumables/Reagents
Instruments
Software
Services
Technology Types
Label-Free Technology
Cell-Based Assay
Others

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

High Throughput Screening (HTS): A Prelude
HTS: The Mainstream Technology for Drug Discovery Programs
Unparalleled Advantages in Compound Screening Drives Wider Adoption
Key Benefits of HTS – An Overview
Investigate Vast Number of Modulators
Accelerated Target Interrogation
Generate Highly Relevant Data for Latter Stage Screening
Scaling Efficiency
Reduced Costs
Soaring R&D Spending Creates Conducive Environment for HTS

Table 1. Healthcare Spending as a Percentage (%) of National GDP for Select Developed Nations (2014) (includes corresponding Graph/Chart)
Table 2. Healthcare Spending as a Percentage (%) of National GDP for Select Developing Nations (2014) (includes corresponding Graph/Chart)

Shift towards High Throughput Research Builds Momentum for HTS
Upward Trajectory in Med Tech Sector Generates Parallel Opportunities
Assessing the Impact of Recent Economic Upheavals on HTS Market
Stable Economic Outlook to Keep Market Sentiment Intact in the Near Term

2. KEY MARKET TRENDS & GROWTH DRIVERS

Cell-based Assay: The Widely Used HTS Technology
Resolving Technical Limitations: Cornerstone for Future Success of Cell-based HTS
HTS Aims to Expand Use Case in Biochemical Applications
Label-Free HTS Demonstrates Fastest Growth
Lab-on-a-Chip HTS Seeks to Proliferate the Market
Bioinformatics HTS Enhanced with Computational Algorithms
Positive Prognosis across End-Use Markets to Underpin Revenue Growth

Table 3. Global High Throughput Screening Market by End-Use Sector (2015): Percentage Breakdown of Revenues for Academia, Biotechnology, Contract Research Organizations (CROs), Government R&D, Pharmaceutical and Other Sectors (includes corresponding Graph/Chart)

Pharmaceutical Industry Leads the Way
HTS Deployments Soar in Academia
Progressive Advancements in HTS Instruments Accelerate Market Growth
Microplate Handling Systems: An Important HTS Instrument Type
Microplates
Microplate Readers
Liquid Handling Devices: A Necessity in HTS Processes
Microscopic Systems Facilitate Seamless Quantitative Analysis
Advanced Software Platforms Augment HTS Proficiency
Services: An Important Revenue Generating Segment
Expansion in Compound Libraries Widens Functional Scope of HTS
Compound Libraries Facilitate Simultaneous Functional Genomics & Small Molecule Analysis
Laboratory Automation & Miniaturization Spell Opportunities for HTS
Miniaturization of Compound Screening Processes Drives Demand for HTS
HTS Miniaturization – Technology Developments
HTS Robotics Support Miniaturization
IVC – A Miniaturized, Powerful HTS Technology
HTS Assumes Critical Importance in Target Identification & Validation
HTS Gathers Steam in Primary Screening Applications
HTS Perceives Bright Future in Stem Cell Research
HTS in Kinase Inhibitors Identification
HTS in Alzheimer’s Disease Drug Discovery
HTS for Less Simplified PCR Systems
HTFC Eases Metabolic Activity Analysis for Pharmaceutical Drugs
Open Access Platforms Widen HTS Audience Base
Need for Stringent QA System to Keep Failures at Bay
High Throughput Screening (HTS) Vs. High Content Screening (HCS)
Rise in Adoption of HCS Technology in HTS Laboratories

3. PRODUCT OVERVIEW

High Throughput Research (HTR)
High Throughput Screening (HTS)
HTS Product Types
Consumables/Reagents
Instruments
Software
Services
HTS Technologies
Label-Free Technology
Cell-Based Assay
Others
HTS Process: An Overview
Functional and Non-Functional – Two Types of High Throughput Assays
HTS: A Historical Perspective

4. DRUG DISCOVERY – AN OVERVIEW

Drug Discovery – Definition
Drug Discovery Process
Drug Discovery Technologies
Computer Aided Drug Discovery (CADD)
The Evolution of Computer Aided Drug Discovery (CADD) Processes
High Throughput Screening
Virtual Screening
Cloud Computing
Hit and Lead Generation Strategies
Different Stages in Hit and Lead Generation
From ‘Hit’ to ‘Lead’ in HTS – A Complex Endeavor

5. PRODUCT INNOVATIONS/INTRODUCTIONS

BD Rolls Out BD CLiC System
Molecular Devices Unveils Upgraded Version of MetaXpress High-Content Image Acquisition and Analysis Software
Crown Bioscience Unveils Huscreen High Throughput Oncology Service Platform
Catalent Pharma Solutions Extends OptiForm Solution Suite for Macromolecule Rapid Screening
OptraSCAN Unveils Subscription Scheme for High Throughput Whole Slide Imaging
Core Informatics Unveils New Applications for Therapeutic Biologics Discovery & Development
Horizon Discovery Introduces New High Throughput Platform for Immuno-Oncology Research
Bruker Unveils MALDI PharmaPulse HTS Platform
BellBrook Labs Launches TR-FRET Version of Transcreener UDP HTS Assay

6. RECENT INDUSTRY ACTIVITY

AstraZeneca Collaborates with IntelliCyt
Massachusetts General Hospital Teams Up with IntelliCyt
Twist Bioscience Expands Collaboration with Ginkgo Bioworks
Icagen Acquires Ultra High-Throughput Assets Sanofi
Albany Molecular Research and New York Center for Nanomedicine Research Team Up
Genedata Extends License Deal with Ono Pharmaceutical
IDBS and Cancer Research Technology Team Up
PerkinElmer Acquires Vanadis Diagnostics
Aptuit Acquires Exquiron Biotech
BGI Selects Solvay’s KetaSpire PEEK for its BGISEQ-500 HTS System
Novogene and AITbiotech to Establish NovogeneAIT Genomics Singapore
Teva Pharmaceutical Industries Collaborates with AbCellera
Merck Acquires Sigma-Aldrich
JEOL USA Teams Up with IMRI
CIRCE Teams Up with Freeslate
Dow AgroSciences Inks License Agreement with Critical Path Services
TMG Collaborates with Verdeca
Albany Molecular Research Signs Collaborative Agreement with Multispan
Cyprotex Inaugurates New HTS Laboratory in the US
The Institut Pasteur Inks Partnership Agreement with IntegraGen
Charles River Laboratories Acquires Oncotest
Exquiron Inks Partnership Agreement with SAMDI Tech
Vaccinogen Inks Option Agreement with Dublin City University
Thermo Fisher Acquires Life Technologies
Horizon Discovery to Acquire cHTS Service Business of Zalicus
Axxam Collaborates with Cellectis Bioresearch
Charles River to Acquire BioFocus and Argenta from Galapagos

7. FOCUS ON SELECT GLOBAL PLAYERS

Agilent Technologies, Inc. (US)
Aurora Biomed, Inc. (Canada)
Axxam SpA (Italy)
BD Biosciences (US)
Danaher Corporation (US)
Beckman Coulter, Inc. (US)
Molecular Devices Inc. (US)
Bio-Rad Laboratories, Inc. (US)
BioTek Instruments Inc. (US)
BMG LABTECH GmbH (Germany)
Charles River Laboratories International, Inc. (US)
Corning Inc. (US)
DiscoveRx Corporation (US)
Evotec AG (Germany)
F. Hoffmann-La Roche Ltd. (Switzerland)
ForteBio (US)
Genedata AG (Switzerland)
IntelliCyt Corporation (US)
Luminex Corporation (US)
PerkinElmer, Inc. (US)
Sigma-Aldrich Corp. (US)
Tecan Group Ltd. (Switzerland)
Thermo Fisher Scientific Inc. (US)

8. GLOBAL MARKET PERSPECTIVE

Table 4. World Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 5. World Historic Review for High Throughput Screening (HTS) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 6. World 14-Year Perspective for High Throughput Screening (HTS) by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 7. World Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments, and Other Products Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 8. World Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments, and Other Products Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 9. World 14-Year Perspective for High Throughput Screening (HTS) by Product Type - Consumables/ Reagents, Instruments, and Other Products Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 10. World Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Technology Type - Label-Free Technology, Cell-Based Assay, and Other Technology Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 11. World Historic Review for High Throughput Screening (HTS) by Technology Type - Label-Free Technology, Cell-Based Assay, and Other Technology Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 12. World 14-Year Perspective for High Throughput Screening (HTS) by Technology Type - Label-Free Technology, Cell-Based Assay, and Other Technology Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A. Market Analysis
Market Overview
HTS Assumes Critical Importance in Drug Discovery Projects
Spending on HTS Soars in Pharmaceutical Sector
Cell-Based Assays Gain Popularity
HTS Outsourcing Gathers Steam
Product Launches
Strategic Corporate Developments
Key Players
B. Market Analytics

Table 13. US Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 14. US Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

2. CANADA

A. Market Analysis
Outlook
Key Player
B. Market Analytics

Table 15. Canadian Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 16. Canadian Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

3. JAPAN

A. Market Analysis
Outlook
Corporate Development
B. Market Analytics

Table 17. Japanese Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 18. Japanese Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4. EUROPE

A. Market Analysis
Outlook
Market Shifts Towards Maturity – Technological Innovations Come to the Rescue
HTS in European Pharmaceutical Industry
Clinical Trials Market in Europe
Innovations in Cell Culture Drive Adoption of Cell-based Assay HTS
Label-Free Technologies Aim to Penetrate the Market
B. Market Analytics

Table 19. European Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 20. European Historic Review for High Throughput Screening (HTS) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 21. European 14-Year Perspective for High Throughput Screening (HTS) by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4A. FRANCE

A. Market Analysis
Outlook
Strategic Corporate Developments
B. Market Analytics

Table 22. French Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 23. French Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4B. GERMANY

A. Market Analysis
Outlook
Corporate Development
Key Players
B. Market Analytics

Table 24. German Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 25. German Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4C. ITALY

A. Market Analysis
Outlook
Key Player
B. Market Analytics

Table 26. Italian Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 27. Italian Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4D. THE UNITED KINGDOM

A. Market Analysis
Outlook
Product Launch
Strategic Corporate Developments
B. Market Analytics

Table 28. The UK Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 29. The UK Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4E. SPAIN

Market Analysis

Table 30. Spanish Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 31. Spanish Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4F. RUSSIA

Market Analysis

Table 32. Russian Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 33. Russian Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4G. REST OF EUROPE

A. Market Analysis
Outlook
Strategic Corporate Developments
Key Players
B. Market Analytics

Table 34. Rest of Europe Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 35. Rest of Europe Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

A. Market Analysis
Asia-Pacific Emerges as Fastest Growing Market for HTS
Pharmaceutical & Biotech Industries Lead the Way
B. Market Analytics

Table 36. Asia-Pacific Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 37. Asia-Pacific Historic Review for High Throughput Screening (HTS) by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 38. Asia-Pacific 14-Year Perspective for High Throughput Screening (HTS) by Geographic Region - Percentage Breakdown of Revenues for China, India and Rest of Asia-Pacific Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

5A. CHINA

A. Market Analysis
Outlook
Opportunities in Expanding Chinese Life Sciences Sector
Growing Drug Discovery Outsourcing Market Bodes Well for Market
Few Problem Areas Exist…
What Outsourcers Need to Look Forward to…
Corporate Development
B. Market Analytics

Table 39. Chinese Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 40. Chinese Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

5B. INDIA

A. Market Analysis
Market Overview
HTS Seeks Role in Indian Pharmaceutical Industry
B. Market Analytics

Table 41. Indian Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 42. Indian Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

5C. REST OF ASIA-PACIFIC

A. Market Analysis
Outlook
Corporate Development
B. Market Analytics

Table 43. Rest of Asia-Pacific Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 44. Rest of Asia-Pacific Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

6. LATIN AMERICA

Market Analysis

Table 45. Latin American Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 46. Latin American Historic Review for High Throughput Screening (HTS) by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 47. Latin American 14-Year Perspective for High Throughput Screening (HTS) by Geographic Region - Percentage Breakdown of Revenues for Brazil and Rest of Latin America Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

6A. BRAZIL

Market Analysis

Table 48. Brazilian Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 49. Brazilian Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

6B. REST OF LATIN AMERICA

Market Analysis

Table 50. Rest of Latin America Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 51. Rest of Latin America Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

7. REST OF WORLD

A. Market Analysis
Outlook
Corporate Development
B. Market Analytics

Table 52. Rest of World Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 53. Rest of World Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 104 (including Divisions/Subsidiaries - 107)
The United States (64)
Canada (2)
Japan (2)
Europe (34)
  France (4)
  Germany (7)
  The United Kingdom (10)
  Italy (1)
  Spain (1)
  Rest of Europe (11)
Asia-Pacific (Excluding Japan) (5)
Skip to top


Ask Your Question

High Throughput Screening (HTS): Market Research Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: